SWOT Analysis for Cytosorbents Corp

Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Top Losers
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Declining Revenue every quarter for the past 2 quarters
Top Losers